A B S T R A C T Insulin, as well as other ligands which increase intracellular guanosine 3',5'-cyclic monophosphate (cGMP), augments thymic-derived (T)-lymphocyte effector activity as revealed by alloimmune lymphocyte-mediated cytotoxicity. The observation that insulin binds only to monocytes among circulating nonimmune human mononuclear cells fostered reexamination of the mechanism by which insulin augments T-lymphocyte function. This report concerns a test of the hypothesis that the T cell is directly affected by insulin and that an insulin receptor emerges upon T lymphocytes consequent to immune activation. Spleens were removed from rats skin grafted across a major histocompatibility barrier. Lymphocytes were harvested from Ficoll-Hypaque density gradients and subsequently enriched for T cells by passage over one or two nylon wool columns. This population was composed of more than 95% T cells as assessed by surface marker techniques (Ig staining, erythrocyte antibody, and erythrocyte antibody complement rosetting, anti-T staining). There was no loss of augmentation of lymphocyte-mediated cytotoxicity induced by insulin, carbamycholine, and 8-bromocGMP in the purified cells when compared to unfractionated cells 7 days after transplantation. 125I-insulin bound saturably to the allostimulated T-enriched lymphocytes with maximum binding at 12.8+0.2 pg and a dissociation constant at equilibrium of 1.3 nM. In contrast, insulin receptors were not present on nonimmune T-enriched cells or on T cells from animals that received syngeneic grafts. The affinity of the lymphocyte insulin receptor was similar to that of more conventional insulin-sensitive tissues e.g., liver, A portion ofthis work was presented in abstract form in; 1976. Clin. Res. 24: 337. Dr.
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INTRODUCTION
The initial step in the action of most polypeptide hormones is a reversible interaction between free, unbound hormone and specific hormone receptor sites on the plasma membrane of a target cell (1) (2) (3) (4) . Such an interaction of ligand with receptor can be quantitatively analyzed utilizing mathematical constructs that define substrate-enzyme relationships (5) . The characterization of the binding of insulin to its receptor has been extensively studied in a multiplicity of insulinsensitive tissues including fat cells, fat cell membranes, liver cell membranes, and intact hepatocytes (4, (6) (7) (8) (9) (10) . Insulin has been shown to bind to mononuclear lymphoid cells and to augment certain of their immunologic functions. The identity of the lymphoid cells capable of reversible insulin binding has been subject to controversy. Gavin and Archer and their respective co-workers could demonstrate that both bone marrowderived (B) lymphoblastoid cell lines maintained in culture and Ficoll-Hypaque (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) purified peripheral blood mononuclear leukocytes from normal blood donors had insulin receptors (11, 12) . Krug et al. (13) could not detect such receptors on resting leukocytes collected after passage through nylon wool columns. The studies of Schwartz et al. (14) clearly demonstrated that insulin binding in any mixture of normal human peripheral blood mononuclear leukocytes is correlated to the presence of nylon wool-adherent monocyte macrophages and not to lymphocytes of either thymic-derived (T) or B pedigrees. Consequently, cells partially purified by techniques which enrich specific cell populations, i.e. B or T cells, but do not delete monocytes, will demonstrate insulin binding. In contrast, cells collected by procedures which deplete macrophages, such as passage through a nylon wool column (15) (16) (17) (18) , will not bind insulin (14, 19) .
Previously reported data have demonstrated that the ability of alloimmune splenic lymphocytes to lyse specifically 51Cr-labeled donor cells is augmented by physiologic concentrations of insulin (20) . The cell effecting lysis in the absence of insulin is a T lymphocyte (21) (22) (23) . However, the absence of insulin receptors upon nonimmune human circulating T lymphocytes and the presence of monocyte macrophages and B cells in the insulin-treated spleen populations leave the mechanism of insulin-augmented lymphocyte-mediated cytotoxicity (LMC)1 in doubt.
An intriguing report by Krug et al. (13) indicated that cells passed through nylon wool, presumably enriched for T lymphocytes and depleted of macrophages and B cells, develop an insulin receptor de novo after nonspecific mitogen stimulation by the plant lectin, concanavalin A. The study reported herein tests the hypothesis that resting T lymphocytes develop an insulin receptor after specific immune activation.
The cholinergic agonists, carbamylcholine and acetylcholine, which share with insulin the ability to increase intracellular guanosine 3',5'-cyclic monophosphate (cGMP) (24-26) through activation of guanylate cyclase and exogenous 8-bromo-cGMP also enhance LMC (20, (27) (28) (29) (30) . It is possible that these agents do not influence LMC by directly altering the function of cytotoxic T lymphocytes since they also affect other cell types which might be involved (31) (32) (33) (34) . Therefore, the ability of insulin, cholinergic agonists, and 8-bromo-cGMP to augment LMC directly by affecting T cells was assessed utilizing B-and macrophage-depleted alloimmune-attacking cell populations.
METHODS
Cell preparation. Alloimmunization was accomplished by placing a skin graft from a (Lewis x Brown Norway) F1 male rat onto a male Lewis rat. 7 days after grafting, spleens from the recipient animals were explanted after exsanguination. The cell suspension was produced by gently grinding the spleen through a 60-gauge steel mesh into RPMI-1640 media (Grand Island Biological Co., Grand Island, N. Y.), buffered with 0.5 volume % of Hepes and enriched with 5% (vol/vol) fetal calf serum (Grand Island Biological Co.). The suspension was washed once and layered on a FicollHypaque gradient (1.0956 d). Leukocytes were collected from the interface and washed twice. Cell suspensions from unIAbbreviations used in this paper: C, complement; EA, erythrocyte antibody rosette; kd, dissociation constant at equilibrium; LMC, lymphocyte-mediated cytotoxicity.
grafted Lewis rats or those Lewis rats given svngeneic skin grafts 7 days previously were prepared in the same manner. Aliquots of cells were utilized for the various studies detailed below.
Surface markers. Cells bearing receptors for the Fc portion of IgG were identified by formation of rosettes with ox erythrocytes complexed with IgG rabbit anti-ox erythrocyte antibodies (EA rosette) using a modification of the technique of Soulillou and co-workers (35) . Cells bearing a receptor for complement (C) were detected by their ability to form rosettes with EAC indicator cells as previously described (35) . Enumeration of lymphoid cells bearing surface Ig was performed by microscope inspection of cell suspensions incubated with fluorescein isothiocyanate-conjugated rabbit polyvalent anti-rat Ig (Cappel Laboratories, Inc., Downingtown, Pa.) (36) . T lymphocytes were characterized by the microscope enumeration ofcells with surface staining offluoresceinlabeled antibody directed against rat brain rendered specific for T cells by the method of Golub (37, 38) . Macrophages were identified by morphologic criteria using acridine orange which was diluted with phosphate-buffered saline and added to 0.5 x 106 leukocytes to a final dilution of 1:106 for 10 min at 24°C. The cells were examined after washing four times in buffered Hanks' solution. The robust cytoplasmic staining of macrophages allowed easy differentiation from lymphocytes (39, 40) . We have previously determined that the cells identified as macrophages by this technique are identical to those bearing macrophage cytochemical characteristics utilizing pararosanilin solution. 2 Insulin-binding assay. Spleen cells prepared as described above were washed twice in Hanks' solution, pH 7.4, containing 0.1% 5x recrystallized bovine serum albumin (Miles Laboratories, Inc., Elkhart, Ind.) and resuspended in this medium at 10 x 100 cells/ml. 1251-insulin (supplied by New England Nuclear, Boston, Mass.) at a sp act of -100 ,uCi/,Lg was prepared by the modification of Freychet et al. (6) of the Hunter and Greenwood method (41) . The preparation is more than 90%'o monoiodinated (6) and biologically active (41, 42) . A 200-pJ aliquot of cells (2 x 100 cells/ml) was placed in siliconized 10 x 12-mm test tubes. To one set of triplicates 20 ,ul of porcine monocomponent insulin was added to a final concentration of4 ,ug/ml; to another set, 20 Al ofthe buffer was added. After a 10-min incubation at 24°C, 20 ,ul of 125-insulin (final concentrations ranging from 0 to 40 ng/ml) was added to replicate reaction mixtures and incubated for 45 min at 24°C. The incubations were terminated by a modification of the method of Gammeltoft and Gliemann (43, 44) . To allow cells to sediment through the oil thus separating from the unbound label, the oil mixture was altered to be one part dinonyl phthalate: two parts dibutyl phthalate (vol/vol). Apparent binding affinity was estimated as the concentration giving half-maximal binding (apparent kd or Ki) and calculated for each experiment by using a Hanes transformation of the binding data (45) for which the x-intercept provides the negative of the dissociation constant at equilibrium (kd)-Depletion of T cells. An antiserum to the Thy 1.1 antigen present on AKR murine thymocytes with cross-reacts with rat splenic T cells was raised in C3H mice as described by Reif and Allen (46 splenocytes on thymocytes bearing alloantigens to which they are sensitized (LMC) was determined by a previously described modification (27, 28) Cell surface markers. Cell surface marker studies on the cell populations utilized in this study are summarized in Table I . The passage of FicollHypaque-harvested cells through nylon wool twice produced a population composed of 95% T lymphocytes and devoid of cells with the appearance of macrophages as assessed by acridine orange staining. Surface Ig-positive lymphocytes constituted 3% of the total cells. The number of cells that form EA rosettes among nylon wool-filtered cells is small (4-6%), and closely approximated the number of B cells as determined by surface Ig staining. Polymorphs were easily excluded from EA scoring because of their easily identifiable nuclear morphology. Cells demonstrating a surface receptor for complement formed a small percentage of the nylon wool-filtered cells. These cells had morphologic characteristics of lymphocytes and were present in numbers that again approximated closely the numbers of the Ig-positive B cells.
Lymphocyte-mediated cytotoxicity. As previously reported, increased LMC was discerned when the sensitized attacking cells were preincubated with optimal concentrations of the pharmacologic agents, insulin (0.1-1 nM), carbamylcholine (1-10 pM), and 8-bromo-cGMP (5 ,uM) for 1-8 min before the introduction of target cells. The maximal pharmacologic augmentation ofLMC produced in each cell pool was compared using Ficoll-Hypaque-purified populations and an aliquot of cells from the same pool passed through nylon wool. It is readily apparent that nylon wool filtration did not alter the degree of pharmacologically augmented cell lysis (Table II) . Elimination of cells adherent to plastic petri dishes also failed to alter the magnitude of pharmacologically augmented LMC (Table II) .
Insulin binding. Insulin does not bind to the membranes of nylon wool-filtered lymphocytes harvested from unimmunized Lewis animals ( Fig. 1) . Nonadherent lymphocytes harvested 7 days after syngeneic skin grafting also failed to bind insulin.
In contrast, specific binding of insulin to nylon wool, effluent lymphocytes harvested from Lewis rats 7 days after allogeneic skin grafting is demonstrable. This binding exhibits saturable kinetics (Fig. 1) . The halfmaximal saturation, an index of apparent kd, occurred at a mean of 1.3 nM which is almost precisely the same affinity for binding to nylon nonadherent lymphocytes (T lymphocytes by inference) found by Krug and her co-workers (1 nM) (13) . If the assumption is made that all T lymphocytes bind insulin equally on their membranes, one can calculate from the maximum binding of 12.8+0.2 pg (1.3 x 109 molecules) (mean-+ SEM) to the 2 x 106 cells present in each assay that there are 671+82 molecules of peptide bound per cell; however, it is unlikely that all of the T lymphocytes in the cell suspension bind insulin. A Hanes transformation of the data (Fig. 2) gives 0.9 nM for the kd of the receptor lending support to the presence of a binding site that efficiently binds nanomolar concentrations of insulin. alloimmune rat splenic lymphocytes to destroy cells bearing the immunizing alloantigens. Activators of adenylate cyclase inhibit cytotoxicity (27, 28, 30, 48, 49) whereas ligands reported to activate guanylate cyclase such as cholinergic agonists (28, 29) and insulin (20) augment LMC. LMC is mounted by alloimmune cytotoxic T lymphocytes; however, nonimmune human circulating blood T lymphocytes do not bear a receptor for insulin (14) .
The data described herein demonstrate that in vivo alloimmunization results in the appearance in rat Tsplenic lymphocyte populations of receptors with the ability to bind insulin with saturation kinetics. T lymphocytes in the resting state or after syngeneic skin grafting do not bind insulin (Fig. 1) . The identification of insulin-binding cells as alloimmune lymphocytes is crucial to the reconciliation of the view that resting mononuclear leukocytes collected on FicollHypaque gradients have insulin receptors (11, 12) , whereas T-enriched nonimmune cells percolated through columns packed with nylon wool have none (13, 14) . Since Schwartz et al. (14) identified the insulin-binding cells in peripheral blood as nylon wool-adherent macrophage monocytes, pains were taken to eliminate macrophage monocytes by the techniques employed by these workers (Table I) Table II demonstrate that T-enriched, B-depleted, and macrophage-free nylon wool-filtered populations are equally responsive to the immunopotentiating properties of 8-bromocGMP, carbamylcholine, and insulin. Similarly, the elimination of cells adherent to petri dishes did not diminish the magnitude of pharmacologically augmented LMC (Table II) . Since these agents do not cause the development of cytotoxicity in nonimmune populations, it seems certain that insulin, carbamylcholine, and 8-bromo-cGMP exert their influence upon activated T lymphocytes and probably directly upon cytotoxic T lymphocytes.
The appearance or unmasking of the receptor could be a marker of lymphocyte activation without playing an inherent role in the events of immune function. The fact that lymphoblasts from leukemia patients and normal lymphocytes transformed by the plant lectin concanavalin A (13) develop these receptors support the view that the appearance of an insulin receptor occurs as a consequence of T-cell activation. However, the fact that insulin can augment at least one immune function of sensitized lymphocytes, i.e. LMC, suggests a substantive physiologic role for insulin and its receptor in modulating the character and vigor of imunological processes. Alloimmune T cells develop insulin receptors as they develop the ability to attack and destroy allogeneic target cells to which they have been immunized with the result that immune "killer" function can be augmented by the ligand, insulin (20) . Because of the requirement that the attacking cells be exposed to insulin for a precise time interval before introduction of target cells (20) , it is unlikely that the peptide functions in a nonspecific manner. This timedependent, optimal dose-dependent enhancement of T-cell function (as measured by the LMC) suggests a functional link between insulin binding and immune response.
